CODX
Co-Diagnostics Inc
Price:  
0.31 
USD
Volume:  
1,262,880
United States | Health Care Equipment & Supplies

CODX WACC - Weighted Average Cost of Capital

The WACC of Co-Diagnostics Inc (CODX) is 6.1%.

The Cost of Equity of Co-Diagnostics Inc (CODX) is 7.5%.
The Cost of Debt of Co-Diagnostics Inc (CODX) is 5%.

RangeSelected
Cost of equity6.3% - 8.7%7.5%
Tax rate4.5% - 12.2%8.35%
Cost of debt5.0% - 5.0%5%
WACC5.6% - 6.5%6.1%
WACC

CODX WACC calculation

CategoryLowHigh
Long-term bond rate3.9%4.4%
Equity market risk premium4.6%5.6%
Adjusted beta0.540.68
Additional risk adjustments0.0%0.5%
Cost of equity6.3%8.7%
Tax rate4.5%12.2%
Debt/Equity ratio
11
Cost of debt5.0%5.0%
After-tax WACC5.6%6.5%
Selected WACC6.1%

CODX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CODX:

cost_of_equity (7.50%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.54) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.